Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE26.8500
- TODAY'S CHANGE (%)-0.4800 (-1.7563%)
- Bid / Lots26.8000/ 3
- Ask / Lots27.1600/ 1
- Open / Previous Close27.2300 / 27.3300
- Day Range
- 52 Week Range
- Volume2,687,694
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 29942 | 27.24 |
| 09:34 ET | 14193 | 27.16 |
| 09:36 ET | 6300 | 27.2 |
| 09:38 ET | 9036 | 27.18 |
| 09:39 ET | 3648 | 27.18 |
| 09:41 ET | 6636 | 27.24 |
| 09:43 ET | 11770 | 27.27 |
| 09:45 ET | 16038 | 27.31 |
| 09:48 ET | 6595 | 27.295 |
| 09:50 ET | 3507 | 27.31 |
| 09:52 ET | 4544 | 27.29 |
| 09:54 ET | 14432 | 27.23 |
| 09:56 ET | 2325 | 27.24 |
| 09:57 ET | 5858 | 27.3 |
| 09:59 ET | 11470 | 27.31 |
| 10:01 ET | 19736 | 27.29 |
| 10:03 ET | 12256 | 27.25 |
| 10:06 ET | 2811 | 27.275 |
| 10:08 ET | 3265 | 27.245 |
| 10:10 ET | 8084 | 27.2 |
| 10:12 ET | 3131 | 27.23 |
| 10:14 ET | 115738 | 27.09 |
| 10:15 ET | 22080 | 27.07 |
| 10:17 ET | 3269 | 27.11 |
| 10:19 ET | 5148 | 27.12 |
| 10:21 ET | 3180 | 27.1101 |
| 10:24 ET | 24745 | 27.115 |
| 10:26 ET | 3247 | 27.095 |
| 10:28 ET | 9683 | 27.035 |
| 10:30 ET | 4771 | 27.075 |
| 10:32 ET | 2700 | 27.09 |
| 10:33 ET | 3825 | 27.11 |
| 10:35 ET | 5959 | 27.11 |
| 10:37 ET | 2500 | 27.12 |
| 10:39 ET | 1834 | 27.16 |
| 10:42 ET | 1690 | 27.145 |
| 10:44 ET | 5641 | 27.145 |
| 10:46 ET | 1720 | 27.14 |
| 10:48 ET | 3298 | 27.095 |
| 10:50 ET | 3606 | 27.085 |
| 10:51 ET | 9649 | 27.11 |
| 10:53 ET | 2275 | 27.115 |
| 10:55 ET | 5436 | 27.145 |
| 10:57 ET | 3034 | 27.115 |
| 11:00 ET | 1881 | 27.1201 |
| 11:02 ET | 3069 | 27.105 |
| 11:04 ET | 4892 | 27.106 |
| 11:06 ET | 1200 | 27.115 |
| 11:08 ET | 8089 | 27.115 |
| 11:09 ET | 3460 | 27.11 |
| 11:11 ET | 2446 | 27.125 |
| 11:13 ET | 10542 | 27.13 |
| 11:15 ET | 5363 | 27.115 |
| 11:18 ET | 14757 | 27.09 |
| 11:20 ET | 5939 | 27.07 |
| 11:22 ET | 2000 | 27.075 |
| 11:24 ET | 14348 | 27.055 |
| 11:26 ET | 2133 | 27.06 |
| 11:27 ET | 8386 | 27.1 |
| 11:29 ET | 5594 | 27.09 |
| 11:31 ET | 4974 | 27.0925 |
| 11:33 ET | 3800 | 27.086 |
| 11:36 ET | 4758 | 27.085 |
| 11:38 ET | 4724 | 27.095 |
| 11:40 ET | 700 | 27.095 |
| 11:42 ET | 2813 | 27.115 |
| 11:44 ET | 1904 | 27.1 |
| 11:45 ET | 4876 | 27.1 |
| 11:47 ET | 1949 | 27.105 |
| 11:49 ET | 3235 | 27.1 |
| 11:51 ET | 200 | 27.1 |
| 11:54 ET | 5836 | 27.0968 |
| 11:56 ET | 5020 | 27.09 |
| 11:58 ET | 3456 | 27.115 |
| 12:00 ET | 200 | 27.12 |
| 12:02 ET | 2478 | 27.115 |
| 12:03 ET | 144599 | 27.0095 |
| 12:05 ET | 5470 | 27.02 |
| 12:07 ET | 25327 | 27.03 |
| 12:09 ET | 5421 | 27.09 |
| 12:12 ET | 3900 | 27.085 |
| 12:14 ET | 4569 | 27.08 |
| 12:16 ET | 2200 | 27.09 |
| 12:18 ET | 7112 | 27.055 |
| 12:20 ET | 1111 | 27.045 |
| 12:21 ET | 2400 | 27.045 |
| 12:23 ET | 5097 | 27.0612 |
| 12:27 ET | 903 | 27.065 |
| 12:30 ET | 4239 | 27.07 |
| 12:32 ET | 8759 | 27.07 |
| 12:34 ET | 3161 | 27.04 |
| 12:36 ET | 659 | 27.05 |
| 12:38 ET | 5442 | 27.03 |
| 12:39 ET | 4909 | 27.04 |
| 12:41 ET | 100 | 27.05 |
| 12:43 ET | 6479 | 27.05 |
| 12:45 ET | 2215 | 27.035 |
| 12:48 ET | 29350 | 27.015 |
| 12:50 ET | 301 | 27.02 |
| 12:52 ET | 1583 | 27.005 |
| 12:54 ET | 6214 | 27 |
| 12:56 ET | 13130 | 27.005 |
| 12:57 ET | 2449 | 27 |
| 12:59 ET | 100 | 27.005 |
| 01:01 ET | 2256 | 27.0101 |
| 01:03 ET | 2769 | 27.01 |
| 01:06 ET | 100 | 27.02 |
| 01:08 ET | 5813 | 27.005 |
| 01:10 ET | 3585 | 27 |
| 01:12 ET | 4573 | 27 |
| 01:14 ET | 900 | 27.005 |
| 01:15 ET | 1200 | 27.005 |
| 01:17 ET | 10063 | 26.99 |
| 01:19 ET | 21950 | 26.995 |
| 01:21 ET | 2097 | 26.97 |
| 01:24 ET | 2361 | 26.975 |
| 01:26 ET | 1719 | 26.995 |
| 01:28 ET | 3233 | 27 |
| 01:30 ET | 1500 | 27.025 |
| 01:32 ET | 8992 | 27.02 |
| 01:33 ET | 826 | 27.015 |
| 01:35 ET | 2266 | 27 |
| 01:37 ET | 4932 | 26.97 |
| 01:39 ET | 4688 | 26.975 |
| 01:42 ET | 7278 | 26.985 |
| 01:44 ET | 3247 | 26.95 |
| 01:46 ET | 4400 | 26.93 |
| 01:48 ET | 5027 | 26.965 |
| 01:50 ET | 1943 | 26.99 |
| 01:51 ET | 2082 | 26.985 |
| 01:53 ET | 6804 | 26.99 |
| 01:55 ET | 3382 | 26.98 |
| 01:57 ET | 9482 | 26.945 |
| 02:00 ET | 1692 | 26.935 |
| 02:02 ET | 7514 | 26.915 |
| 02:04 ET | 2330 | 26.905 |
| 02:06 ET | 3121 | 26.915 |
| 02:08 ET | 3600 | 26.91 |
| 02:09 ET | 774 | 26.915 |
| 02:11 ET | 2250 | 26.915 |
| 02:13 ET | 1574 | 26.915 |
| 02:15 ET | 3208 | 26.955 |
| 02:18 ET | 3532 | 26.9395 |
| 02:20 ET | 2563 | 26.925 |
| 02:22 ET | 1200 | 26.925 |
| 02:24 ET | 9005 | 26.93 |
| 02:26 ET | 903 | 26.93 |
| 02:27 ET | 9558 | 26.885 |
| 02:29 ET | 1001 | 26.885 |
| 02:31 ET | 1324 | 26.88 |
| 02:33 ET | 8229 | 26.9 |
| 02:36 ET | 2308 | 26.91 |
| 02:38 ET | 2960 | 26.905 |
| 02:40 ET | 1654 | 26.915 |
| 02:42 ET | 3083 | 26.91 |
| 02:44 ET | 918 | 26.9 |
| 02:45 ET | 1586 | 26.905 |
| 02:47 ET | 4430 | 26.905 |
| 02:49 ET | 1500 | 26.8999 |
| 02:51 ET | 5300 | 26.88 |
| 02:54 ET | 2289 | 26.86 |
| 02:56 ET | 4486 | 26.8653 |
| 02:58 ET | 1853 | 26.88 |
| 03:00 ET | 3629 | 26.865 |
| 03:02 ET | 5052 | 26.835 |
| 03:03 ET | 10446 | 26.82 |
| 03:05 ET | 5000 | 26.86 |
| 03:07 ET | 3765 | 26.875 |
| 03:09 ET | 11495 | 26.9 |
| 03:12 ET | 884 | 26.895 |
| 03:14 ET | 6061 | 26.86 |
| 03:16 ET | 4853 | 26.87 |
| 03:18 ET | 7440 | 26.865 |
| 03:20 ET | 2293 | 26.875 |
| 03:21 ET | 19131 | 26.875 |
| 03:23 ET | 6446 | 26.875 |
| 03:25 ET | 9064 | 26.885 |
| 03:27 ET | 6883 | 26.91 |
| 03:30 ET | 5441 | 26.91 |
| 03:32 ET | 1200 | 26.92 |
| 03:34 ET | 4326 | 26.9 |
| 03:36 ET | 8700 | 26.935 |
| 03:38 ET | 2226 | 26.94 |
| 03:39 ET | 3349 | 26.93 |
| 03:41 ET | 6637 | 26.93 |
| 03:43 ET | 10732 | 26.915 |
| 03:45 ET | 9194 | 26.91 |
| 03:48 ET | 13085 | 26.8811 |
| 03:50 ET | 16807 | 26.845 |
| 03:52 ET | 25402 | 26.845 |
| 03:54 ET | 25630 | 26.851 |
| 03:56 ET | 30049 | 26.865 |
| 03:57 ET | 20517 | 26.85 |
| 03:59 ET | 88897 | 26.85 |
Yesterday
DJ Cytokinetics Falls 10% on Royalty Pharma Transaction, Stock Offer, from 4:35PM ET on Wednesday May 22, 2024 by Dow Jones
4:35PM ET on Wednesday May 22, 2024 by Dow JonesRoyalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline, from 4:10PM ET on Wednesday May 22, 2024 by Dow Jones
4:10PM ET on Wednesday May 22, 2024 by Dow JonesCytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline, from 4:00PM ET on Wednesday May 22, 2024 by Dow Jones
4:00PM ET on Wednesday May 22, 2024 by Dow Jones
May 17, 2024
DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones
7:31AM ET on Friday May 17, 2024 by Dow Jones
May 13, 2024
Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones
8:15AM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.3B | 15.1x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.4x | --- |
Catalent Inc | 9.9B | -8.4x | --- |
Jazz Pharmaceuticals PLC | 6.7B | 21.4x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.1B | 2.2x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.3B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.13% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.1x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
